Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
Jinyu Zhang, Fahmin Basher, Jennifer D. Wu
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Selenium, Selenoproteins, and Immunity
Joseph C. Avery, Peter R. Hoffmann
Nutrients (2018) Vol. 10, Iss. 9, pp. 1203-1203
Open Access | Times Cited: 738
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4654-4668
Open Access | Times Cited: 664
Control of Metastasis by NK Cells
Alejandro López‐Soto, Segundo González, Mark J. Smyth, et al.
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 135-154
Open Access | Times Cited: 645
Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
Axel Hoos
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 4, pp. 235-247
Closed Access | Times Cited: 551
Driving CAR T-cells forward
Hollie J. Jackson, Sarwish Rafiq, Renier J. Brentjens
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 6, pp. 370-383
Open Access | Times Cited: 547
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, et al.
Science (2018) Vol. 359, Iss. 6383, pp. 1537-1542
Open Access | Times Cited: 378
Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
Lin Xiao, Dongzhi Cen, Haining Gan, et al.
Molecular Therapy (2019) Vol. 27, Iss. 6, pp. 1114-1125
Open Access | Times Cited: 229
NKG2D and Its Ligands: “One for All, All for One”
Alessandra Zingoni, Rosa Molfetta, Cinzia Fionda, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 216
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment
Tristan Courau, Julie Bonnereau, Justine Chicoteau, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 202
NKG2D and its ligands in cancer
Payal Dhar, Jennifer D. Wu
Current Opinion in Immunology (2018) Vol. 51, pp. 55-61
Open Access | Times Cited: 188
Natural killer cell cytotoxicity and its regulation by inhibitory receptors
Santosh Kumar
Immunology (2018) Vol. 154, Iss. 3, pp. 383-393
Open Access | Times Cited: 187
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
John P. Veluchamy, Nina Kok, Hans van Vliet, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 178
The role of cancer-derived microRNAs in cancer immune escape
Ming Yi, Linping Xu, Ying Jiao, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 176
Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
Yoshiyuki Nakamura
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 171
Landscape of B cell immunity and related immune evasion in human cancers
Xihao Hu, Jian Zhang, Jin Wang, et al.
Nature Genetics (2019) Vol. 51, Iss. 3, pp. 560-567
Open Access | Times Cited: 148
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
Yanlin Yu
Cancers (2023) Vol. 15, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 51
Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets
Greta Pessino, Claudia Scotti, Maristella Maggi
Cancers (2024) Vol. 16, Iss. 5, pp. 901-901
Open Access | Times Cited: 18
Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis
Guy A Conlon, Graeme I. Murray
The Journal of Pathology (2018) Vol. 247, Iss. 5, pp. 629-640
Open Access | Times Cited: 159
Biological roles and potential applications of immune cell‐derived extracellular vesicles
Chuan Wen, Robert C. Seeger, Muller Fabbri, et al.
Journal of Extracellular Vesicles (2017) Vol. 6, Iss. 1
Open Access | Times Cited: 152
NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
Dominik Schmiedel, Ofer Mandelboim
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 147
Role of NKG2D and its ligands in cancer immunotherapy.
Huifang Liu, Sijia Wang, Xin Jing, et al.
PubMed (2019) Vol. 9, Iss. 10, pp. 2064-2078
Closed Access | Times Cited: 123
Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells
Bin Sun, Dong Yang, Hongjiu Dai, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 11, pp. 1813-1823
Open Access | Times Cited: 114
Genetics, genomics, and evolutionary biology of NKG2D ligands
Raphaël Carapito, Seiamak Bahram
Immunological Reviews (2015) Vol. 267, Iss. 1, pp. 88-116
Closed Access | Times Cited: 109
Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion
Linda Ziani, Thouraya Ben Safta-Saadoun, Johanne Gourbeix, et al.
Oncotarget (2017) Vol. 8, Iss. 12, pp. 19780-19794
Open Access | Times Cited: 109
Leveraging NKG2D Ligands in Immuno-Oncology
Mercedes B. Fuertes, Carolina I. Domaica, Norberto W. Zwirner
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top